1. Home
  2. TATT vs CLLS Comparison

TATT vs CLLS Comparison

Compare TATT & CLLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TAT Technologies Ltd.

TATT

TAT Technologies Ltd.

HOLD

Current Price

$36.12

Market Cap

466.9M

Sector

Industrials

ML Signal

HOLD

Logo Cellectis S.A.

CLLS

Cellectis S.A.

HOLD

Current Price

$4.11

Market Cap

384.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TATT
CLLS
Founded
1985
1999
Country
United States
France
Employees
N/A
N/A
Industry
Aerospace
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
466.9M
384.3M
IPO Year
2002
2014

Fundamental Metrics

Financial Performance
Metric
TATT
CLLS
Price
$36.12
$4.11
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
3
Target Price
$57.17
$8.33
AVG Volume (30 Days)
175.9K
28.1K
Earning Date
05-18-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$16.29
N/A
Revenue Next Year
$16.09
$0.98
P/E Ratio
$38.61
N/A
Revenue Growth
N/A
N/A
52 Week Low
$25.52
$1.33
52 Week High
$64.50
$5.48

Technical Indicators

Market Signals
Indicator
TATT
CLLS
Relative Strength Index (RSI) 40.55 52.20
Support Level $33.70 $3.39
Resistance Level $41.27 $4.48
Average True Range (ATR) 1.53 0.18
MACD 0.37 -0.02
Stochastic Oscillator 44.35 54.35

Price Performance

Historical Comparison
TATT
CLLS

About TATT TAT Technologies Ltd.

TAT Technologies Ltd provides solutions and services to the commercial and military aerospace and ground defense industries, focused mainly on three product areas and services: Thermal Management, Power and Actuation, and Maintenance, Repair and Overhaul (MRO). Its product portfolio includes heat exchangers, cooling systems, and mechanical aircraft accessories and systems such as pumps, valves, and turbine power units. Its operating segments are MRO services for aviation components, which derive key revenue, Original equipment manufacturing (OEM) of heat transfer solutions and aviation accessories, MRO services for heat transfer components and OEM of heat transfer solutions, and Overhaul and coating of jet engine components. Geographically, it derives key revenue from the United States.

About CLLS Cellectis S.A.

Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.

Share on Social Networks: